Skip to content

The application of AI-based respiratory wave frequency spectrum analysis in pulmonary function testing and the auxiliary diagnosis of chronic obstructive pulmonary disease (COPD)

The application of AI-based respiratory wave frequency spectrum analysis in pulmonary function testing and the auxiliary diagnosis of chronic obstructive pulmonary disease (COPD)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092649
Enrollment
Unknown
Registered
2024-11-21
Start date
2024-07-19
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

Gold Standard:Routine Pulmonary Function Testing
Index test:Respiratory Wave Spectral Analysis

Sponsors

Fujian Provincial Department of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria for the healthy control group: no history of smoking, no exposure to other risk factors, no respiratory symptoms such as cough, sputum production, or shortness of breath, and no history of other pulmonary diseases or major surgical trauma.

Exclusion criteria

Exclusion criteria: Exclusion criteria: known to have other pulmonary diseases, such as tuberculosis, bronchiectasis, or a history of lung tumors; history of major surgical trauma to the lungs; cognitive impairment that prevents cooperation in completing questionnaires and smart mask examinations.

Design outcomes

Primary

MeasureTime frame
The sensitivity of respiratory spectrometry in the diagnosis of COPD;The specificity of respiratory spectrometry in the diagnosis of COPD ;

Secondary

MeasureTime frame
The mean absolute percentage error of the predicted FVC;The mean absolute percentage error of the predicted FEV1;The mean absolute percentage error of the predicted FEV1/FVC;The mean absolute percentage error of the predicted MMEF;

Countries

China

Contacts

Public ContactBaosong Xie

Department of Respiratory and Critical Care Medicine,Fuzhou University Affiliated Provincial Hospital

xbaosong@126.com+86 137 6386 1681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026